Mindfulness Training for Older Adult Canadian Immigrants
NCT03923452, Not applicable, Completed, Toronto Metropolitan University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mindfulness Training for Older Adult Canadian Immigrants | ClinicalTrials.gov |
| NCT number | NCT03923452 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Toronto Metropolitan University | ClinicalTrials.gov |
| Conditions | Stress | ClinicalTrials.gov |
| Interventions | Mindfulness-based Stress Reduction | ClinicalTrials.gov |
| First posted | 2019-04-22 | ClinicalTrials.gov |
| Last updated | 2025-06-18 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Perceived Stress Scale (PSS) | 2 days (pre-post testing) | the PSS is a 14-item questionnaire that measures general perceived stress. Total Scores range from 0-56, with higher scores denoting greater perceived stress. | ClinicalTrials.gov |
| Primary | Center for epidemiological studies - depression (CES-D) | 2 days (pre-post testing) | The CES-D is a self-report measure of depressive symptoms. Total score ranges from 0-60, with greater scores denoting greater endorsement of depressive symptoms. | ClinicalTrials.gov |
| Secondary | Five Facet Mindfulness Questionnaire (FFMQ) | 2 days (pre-post testing) | The FFMQ is a 33-item self-report measure, that measures mindfulness characteristics including the ability to observe, describe, act with awareness, non-judging, and non-reacting. ". Subscale scores range from 8 to 40 for the observing, describing, acting with awareness, and non-judging facets, or 7 to 35 for the non-reacting facet, resulting in an overall FFMQ score range of 39 to 195. Higher scores indicate greater levels of TM. | ClinicalTrials.gov |
| Other | Difficulties in Emotion Regulation Scale (DERS-16) | 2 days (pre-post testing) | A 16-item Likert-type scale that measure the propensity for emotion regulation. Higher scores indicate greater emotion regulation. | ClinicalTrials.gov |
| Other | Mindful Self-Care Scale- SHORT (MSCS) | 2 days (pre-post testing) | The Mindful Self-Care Scale- SHORT (MSCS, 2016) is a 33-item scale that measures the self-reported frequency of behaviors that measure self-care behavior.The scale addresses 6 domains of self-care: physical care, supportive relationships, mindful awareness, self-compassion and purpose, mindful relaxation, and supportive structure. | ClinicalTrials.gov |
| Other | Stroop Task | 2 days (pre-post testing) | A 15-minute computer-based task that measures attention and inhibition. | ClinicalTrials.gov |
| Other | Self-Compassion Scale (SCS) | 2 days (pre-post testing) | A 26-item Likert-type scale (Almost Never to Almost Always) that measures self-compassion. Greater scores indicate greater self-compassion. | ClinicalTrials.gov |
| Other | Brief Resilience Scale (BRS) | 2 days (pre-post testing) | A 6-item Likert-type scale (Strongly Disagree to Strongly Agree) that measures resilience when faced with challenge and set-backs. Higher scores indicate greater resilience. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Other outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)